Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Valuation
Upturn AI SWOT - About
United-Guardian Inc (UG)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
08/14/2025: UG (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
0 Analysts rated it
Very few follow this stock; limited insights, higher-risk early investing.
Analysis of Past Performance
Type Stock | Historic Profit 14.22% | Avg. Invested days 40 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  2.0 | Stock Returns Performance  2.0 |
| Profits based on simulation | Last Close 08/14/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 37.46M USD | Price to earnings Ratio 12.94 | 1Y Target Price - |
Price to earnings Ratio 12.94 | 1Y Target Price - | ||
Volume (30-day avg) - | Beta 0.92 | 52 Weeks Range 7.73 - 15.74 | Updated Date 06/29/2025 |
52 Weeks Range 7.73 - 15.74 | Updated Date 06/29/2025 | ||
Dividends yield (FY) 8.59% | Basic EPS (TTM) 0.63 |
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin 25.3% | Operating Margin (TTM) 24.62% |
Management Effectiveness
Return on Assets (TTM) 15.65% | Return on Equity (TTM) 26.24% |
Valuation
Trailing PE 12.94 | Forward PE - | Enterprise Value 29334895 | Price to Sales(TTM) 3.28 |
Enterprise Value 29334895 | Price to Sales(TTM) 3.28 | ||
Enterprise Value to Revenue 2.57 | Enterprise Value to EBITDA 8.81 | Shares Outstanding 4594320 | Shares Floating 2949185 |
Shares Outstanding 4594320 | Shares Floating 2949185 | ||
Percent Insiders 35.81 | Percent Institutions 22.79 |
Upturn AI SWOT
United-Guardian Inc
Company Overview
History and Background
United-Guardian, Inc. was founded in 1942. The company develops, manufactures, and markets pharmaceutical and personal care products. It initially focused on the production of pharmaceuticals and over time expanded into the personal care market.
Core Business Areas
- Personal Care Products: Develops and manufactures ingredients used in personal care products, such as lubricants and moisturizers.
- Pharmaceutical Products: Produces and markets pharmaceutical products, including suppositories and other OTC medications.
Leadership and Structure
Ronald J. Marino serves as the president. The company has a traditional hierarchical structure with functional departments such as R&D, manufacturing, sales, and marketing.
Top Products and Market Share
Key Offerings
- Lubrajel: Lubrajel is a water-based moisturizing and lubricating gel used in various personal care and pharmaceutical applications. Competitors include companies producing similar hydrogels and lubricants, and it's hard to specify precise market share due to the diverse applications and fragmented market.
- Suppositories: United-Guardian manufactures and markets various types of suppositories. Competitors include generic pharmaceutical manufacturers, difficult to specify precise market share.
Market Dynamics
Industry Overview
The personal care and pharmaceutical industries are highly competitive and regulated. Key trends include increasing demand for natural and sustainable ingredients, growing aging population and focus on personal health, and evolving regulatory standards.
Positioning
United-Guardian occupies a niche position, focusing on specialty ingredients and OTC products. Its competitive advantages lie in its established brand recognition, manufacturing expertise, and long-standing customer relationships.
Total Addressable Market (TAM)
The combined TAM for personal care ingredients and OTC pharmaceuticals is substantial (hundreds of billions USD). United-Guardian's TAM is smaller because it focuses on specialty markets but the value can be extrapolated into the multiple of hundreds of millions to a few billions. The company is positioned to serve specific niches within these large markets, leveraging its specialized products.
Upturn SWOT Analysis
Strengths
- Established brand reputation
- Specialized product portfolio
- Strong customer relationships
- Consistent profitability
- Debt-free balance sheet
Weaknesses
- Limited product diversification
- Dependence on a few key products
- Small market capitalization
- Low trading volume
- Limited marketing reach
Opportunities
- Expanding into new geographic markets
- Developing new products and applications
- Acquiring complementary businesses
- Partnering with larger companies
- Increased demand for natural and sustainable ingredients
Threats
- Increased competition
- Changing consumer preferences
- Regulatory changes
- Economic downturns
- Raw material price fluctuations
Competitors and Market Share
Key Competitors
- Generic pharmaceutical manufacturers
- Specialty chemical companies
- Personal care product manufacturers
Competitive Landscape
United-Guardian competes with larger companies in the personal care and pharmaceutical industries. Its advantages lie in its specialized products and established brand recognition. Its disadvantages include its limited scale and marketing reach.
Growth Trajectory and Initiatives
Historical Growth: Historical growth has been modest but consistent, reflecting the company's focus on niche markets.
Future Projections: Future growth is projected to be moderate, driven by new product development and market expansion.
Recent Initiatives: Recent strategic initiatives include expanding its product line and strengthening its distribution network.
Summary
United-Guardian is a stable company that has been consistently profitable and returning value to its shareholders through dividends. Its strengths lie in its niche product portfolio, minimal debt, and steady cash flow. It is a stable and potentially interesting, but small, business.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company filings
- Industry reports
- Financial news sources
Disclaimers:
This analysis is for informational purposes only and does not constitute financial advice. Investment decisions should be made based on individual circumstances and consultation with a qualified financial advisor.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About United-Guardian Inc
Exchange NASDAQ | Headquaters Hauppauge, NY, United States | ||
IPO Launch date 1992-03-17 | CEO - | ||
Sector Consumer Defensive | Industry Household & Personal Products | Full time employees 24 | Website https://u-g.com |
Full time employees 24 | Website https://u-g.com | ||
United-Guardian, Inc. develops, manufactures, sells, and markets specialty cosmetic ingredients, pharmaceutical products, medical lubricants, and sexual wellness ingredients in the United States and internationally. The company offers cosmetic ingredients, including LUBRAJEL, a line of multifunctional hydrogel formulations for personal care and medical products; B-122, a powdered lubricant used in the manufacture of certain cosmetics, such as pressed powders, eyeliners, and rouges, as well as some industrial products; ORCHID COMPLEX, an oil-based extract of orchids; and LUBRASIL II SB, a special formulation of Lubrajel in which silicone oil is incorporated into a Lubrajel base. It also provides medical lubricant products for catheter lubrication, medical devices, condom lubrication, and oral care under the Lubrajel brand, including Lubrajel MG, Lubrajel MGL, Lubrajel RRCG, Lubrajel RR, Lubrajel RC, Lubrajel RA, Lubrajel Fluid, Lubrajel LC, Lubrajel BA, and Lubrajel FACO. In addition, the company offers pharmaceutical products comprising RENACIDIN, a prescription to prevent and to dissolve calcifications in urethral catheters; and CLORPACTIN WCS-90, a chlorine-based drug, which is a topical antimicrobial and is also used in urology. Further, it provides sexual wellness ingredient products, which are hydrogel formulations designed to offer sensory enhancement, lubrication, and moisturization, such as Natrajel NT, Natrajel MA, Natrajel ON, and Natrajel TE product lines. United-Guardian, Inc. was founded in 1942 and is based in Hauppauge, New York.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.